Non-Profit Trusted Source of Non-Commercial Health Information
The Original Voice of the American Academy of Anti-Aging, Preventative, and Regenerative Medicine
logo logo
Progesterone Aging Anti-Aging Anti-Aging Research Science

Progesterone and the mTOR Aging System

1 year, 4 months ago

9810  0
Posted on Dec 12, 2022, 6 p.m.

Unraveling how and why we age is a research focus. We are still captivated by the Ponce de Leon promise of the Fountain of Youth. An enzyme system named mTOR (mammalian or mechanistic target of rapamycin) was identified in mouse studies as a significant aging mechanism. Inhibition of mTOR by rapamycin, found in bacteria species: S. cerevisiae, C. elegans, D. melanogaster, or Mus musculus, helped identify mTOR as a central actor.

This schematic and the accompanying explanation help to illustrate the key role of mTOR.

mTOR-Aging-System carol petersen

“Schematic representation of the role of the mTOR pathway in the regulation of hallmarks of aging (black arrows), such as nutrient availability (represented by amino acid availability), energy homeostasis, cellular senescence, cell stemness, and proteostasis. mTOR activity is regulated in part by amino acid levels, while mTOR in turn stimulates the synthesis of non-essential amino acids. The depicted hallmarks of aging are also interconnected (grey arrows), suggesting that aging is a coordinated process in which mTOR plays a significant role. mTOR, mechanistic target of rapamycin kinase.” (1)

Thus using rapamycin, which has been developed as an anticancer drug, emerged as a possible strategy by the anti-aging community.   

Dr. Ray Peat, writing in his newsletter (2,) discusses other mTOR inhibitors. The hormone progesterone tops the list. Researchers found progesterone can bind directly to mitochondria (organelles within the cells that produce energy). Progesterone can increase the energy production in the mitochondria as well as increase the size of the mitochondria. Progesterone inhibits many catabolic (breaking down) processes. Including the aging caused by mTOR.

Other inhibitors include the bioflavonoid from citrus peel, nobiletin, and aspirin.

Substances that increase the aging promoted by mTOR are estrogen, radiation, the amino acids methionine and tryptophan, toxins, and lipofuscins. The protein in gelatin is low in methionine and tryptophan and so becomes a favorable protein source. Lipofuscins are age spots caused by unsaturated fatty acids (PUFAS) and heavy metals. Reducing intake of PUFAS and exposure to heavy metals becomes an antiaging strategy.

As research continues to help unravel the mysteries of the human body, the solutions to optimizing our lifespan may be simple. 

Carol Petersen RPh, CNP

This article was written by Carol Petersen RPh, CNP an accomplished compounding pharmacist with decades of experience helping patients improve their quality of life through bio-identical hormone replacement therapy. She graduated from the University of Wisconsin School of Pharmacy and is a Certified Nutritional Practitioner. Her passion to optimize health and commitment to compounding is evident in her involvement with organizations including the International College of Integrated Medicine and the American College of Apothecaries, the American Pharmacists Association, and the Alliance for Pharmacy Compounding. She was also the founder and first chair for the Compounding Special Interest Group with the American Pharmacists Association. She serves as chair for the Integrated Medicine Consortium. She co-hosts a radio program “Take Charge of Your Health” in the greater New York area. She is on the Medical Advisory Board for the Centre for Menstrual Cycle and Ovulation Research ( To contact Carol click here

As with anything you read on the internet, this article should not be construed as medical advice; please talk to your doctor or primary care provider before changing your wellness routine. This article is not intended to provide a medical diagnosis, recommendation, treatment, or endorsement.

Opinion Disclaimer: The views and opinions expressed in this article are those of the author and do not necessarily reflect the official policy of WHN/A4M. Any content provided by guest authors is of their own opinion and is not intended to malign any religion, ethic group, club, organization, company, individual, or anyone or anything. 

Content may be edited for style and length.

References/Sources/Materials provided by:

(1)  Papadopoli, David et “alTOR as a central regulator of lifespan and aging”    02 Jul 2019, 8(F1000 Faculty Rev):998

(2) “Aging, Energy, Progesterone” Ray Peat’s Newsletter Q2 2022

* Note: Removed the word "Deficiency" from the article title on Dec.13.2022

WorldHealth Videos